Iceland has become the world's premier natural laboratory for human genetics research. The reason isn't high-tech labs (though it has those)—it's the population itself.
Iceland was settled around 874 CE by a small group of Norse and Celtic voyagers. For over 1,100 years, the population remained remarkably isolated—minimal immigration until recent decades. This creates a founder population: a gene pool derived from relatively few ancestors with limited outside mixing.
deCODE genetics (Reykjavík-based, now Amgen subsidiary) has leveraged this to discover genes for Alzheimer's, schizophrenia, coronary artery disease, type 2 diabetes, and numerous cancers. Their database covers ~160,000 volunteers (half the adult population) with whole-genome sequencing.
Iceland's gift to humanity: a population structure that makes the needle visible in the genomic haystack. Ethical safeguards (informed consent, data anonymization, national bioethics committee) make it a model for population genomics worldwide.